After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...

Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...

KOS AI to Host Press Conference on Argus: A Non-Invasive Blood Glucose Monitoring Breakthrough ...

The Clinical Trials Research Pillar in the Division of Biostatistics is at the forefront of innovative clinical trial design ...

A federal judge has blocked the cuts while lawsuits move through the courts but it has caused uncertainty and anxiety among ...

The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of ...

A study indicates ALS Functional Rating Scale-Revised self-assessments using a smartphone app were as reliable as those done ...

Spironolactone's safety profile had been primarily generated from trials of older people with heart failure, so its safety in ...

Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced progress in its Phase 1 clinical trial for OCU200, a novel biologic ...

BENGALURU: For millions of people with diabetes, checking blood glucose levels is a painful yet daily necessity as it ...

Why Norstella, Makersite, Satelytics, and Chainalysis are among Fast Company's Most Innovative Companies in data science for ...